Davis and colleagues reported cleavage of caspase-7 in nelfinavir-treated cisplatin-sensitive and -resistant cervical cancer cells, which corroborated similar findings in breast cancer cells [42,43]. The gene discussed is CASP7; the disease is breast cancer.